Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)

SHE:002653 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	1,457	1,056	1,169	775.39	575.11	453.97
Short-Term Investments	-	-	-	-	-	410
Trading Asset Securities	-	150.13	160.06	-	-	370.32
Cash & Short-Term Investments	1,457	1,206	1,329	775.39	575.11	1,234
Cash Growth	38.16%	-9.23%	71.37%	34.82%	-53.41%	0.91%
Accounts Receivable	1,006	1,077	883.9	803.79	569.97	487.61
Other Receivables	36.71	40.35	46.79	47.14	78.5	68.54
Receivables	1,042	1,117	930.69	850.93	648.47	556.16
Inventory	299.56	271.61	281.29	346	259.95	223.9
Prepaid Expenses	20.24	22.55	-	-	-	-
Other Current Assets	59.23	112.53	100.02	81.32	64.9	81.38
Total Current Assets	2,878	2,730	2,641	2,054	1,548	2,096
Property, Plant & Equipment	859.94	917.09	996.04	1,074	1,137	1,126
Long-Term Investments	130.39	146.99	232.46	422.17	381.19	398.83
Other Intangible Assets	1,335	1,277	751.23	708.33	682.47	599.98
Long-Term Deferred Tax Assets	175.95	177.23	148.24	126.08	83.57	80.6
Long-Term Deferred Charges	1,127	1,107	1,427	1,233	822.42	587.16
Other Long-Term Assets	485.59	443.95	457.37	430.15	350.51	108.15
Total Assets	6,992	6,798	6,653	6,048	5,005	4,997
Accounts Payable	164.72	195.89	208.99	242.44	301.4	419.95
Accrued Expenses	148.86	190.48	200.09	136.68	120.63	93.13
Short-Term Debt	93.84	242.57	99.98	484.69	452.18	740
Current Portion of Long-Term Debt	916.3	728.41	833.59	295.4	325.78	-
Current Portion of Leases	6.09	10.27	7.41	6.64	8	-
Current Income Taxes Payable	6.19	5.49	16.08	16.1	1.71	47.73
Current Unearned Revenue	18.38	20.87	14.61	26.96	28.44	26.02
Other Current Liabilities	165.48	174.23	123.23	279.64	279.98	389.4
Total Current Liabilities	1,520	1,568	1,504	1,489	1,518	1,716
Long-Term Debt	1,292	925	854.68	1,320	452.41	334.9
Long-Term Leases	4.04	4.14	10.85	4.52	10.91	-
Long-Term Unearned Revenue	105.53	95.06	108.47	98.52	102.54	87.14
Long-Term Deferred Tax Liabilities	7.34	3.77	4.01	2.53	1.11	1.33
Other Long-Term Liabilities	-	-	0.38	-	-	2.23
Total Liabilities	2,929	2,596	2,482	2,914	2,085	2,142
Common Stock	1,120	1,120	1,114	1,076	1,077	1,074
Additional Paid-In Capital	983.94	953.57	853.38	100.82	97.62	78.57
Retained Earnings	1,998	2,180	2,210	1,807	1,733	1,787
Treasury Stock	-80.94	-80.94	-9.15	-24.44	-38.31	-24.76
Comprehensive Income & Other	44.14	40.55	11.86	76.41	-26.82	-13.3
Total Common Equity	4,065	4,213	4,180	3,036	2,842	2,902
Minority Interest	-2.04	-11.09	-9.36	97.68	78.27	-47.65
Shareholders' Equity	4,063	4,202	4,171	3,133	2,920	2,855
Total Liabilities & Equity	6,992	6,798	6,653	6,048	5,005	4,997
Total Debt	2,313	1,910	1,807	2,111	1,249	1,075
Net Cash (Debt)	-855.95	-704.22	-477.74	-1,336	-674.16	159.39
Net Cash Growth	-	-	-	-	-	11.29%
Net Cash Per Share	-0.77	-0.62	-0.44	-1.25	-0.63	0.15
Filing Date Shares Outstanding	981.74	1,159	1,048	1,036	1,091	1,137
Total Common Shares Outstanding	981.74	1,159	1,048	1,036	1,091	1,137
Working Capital	1,358	1,162	1,137	565.09	30.32	379.5
Book Value Per Share	4.14	3.63	3.99	2.93	2.61	2.55
Tangible Book Value	2,730	2,937	3,429	2,327	2,159	2,302
Tangible Book Value Per Share	2.78	2.53	3.27	2.25	1.98	2.03
Buildings	909.36	931.33	965.52	922.14	931.62	684.59
Machinery	796.6	789.01	748.62	709.94	677.15	602.24
Construction In Progress	10.19	6.73	5.87	97.9	88.54	335.2

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.